Results
|
52481.
|
Treatment of chronic myelogenous leukemia with interferon alfa-2c: response rate and toxicity in a phase II multicenter study. The Austrian Biological Response Modifier (BRM) Study Group. [electronic resource] by
- Thaler, J
- Gastl, G
- Fluckinger, T
- Niederwieser, D
- Huber, H
- Seewann, H
- Silly, H
- Lang, A
- Abbrederis, C
- Gadner, H
Producer: 19931210
In:
Seminars in hematology vol. 30
Availability: No items available.
|
|
52482.
|
|
|
52483.
|
|
|
52484.
|
|
|
52485.
|
Experimental gene therapy: the transfer of Tat-inducible interferon genes protects human cells against HIV-1 challenge in vitro and in vivo in severe combined immunodeficient mice. [electronic resource] by
- Sanhadji, K
- Leissner, P
- Firouzi, R
- Pelloquin, F
- Kehrli, L
- Marigliano, M
- Calenda, V
- Ottmann, M
- Tardy, J C
- Mehtali, M
- Touraine, J L
Producer: 19970911
In:
AIDS (London, England) vol. 11
Availability: No items available.
|
|
52486.
|
|
|
52487.
|
|
|
52488.
|
Interferon-alpha therapy in patients dually infected with hepatitis C virus and GB virus C/hepatitis G virus--virological response of HGV and pretreatment HGV viremia level. [electronic resource] by
- Orito, E
- Mizokami, M
- Yasuda, K
- Sugihara, K
- Nakamura, M
- Mukaide, M
- Ohba, K I
- Nakano, T
- Kato, T
- Kondo, Y
- Kumada, T
- Ueda, R
- Iino, S
Producer: 19971223
In:
Journal of hepatology vol. 27
Availability: No items available.
|
|
52489.
|
|
|
52490.
|
|
|
52491.
|
|
|
52492.
|
|
|
52493.
|
|
|
52494.
|
|
|
52495.
|
|
|
52496.
|
|
|
52497.
|
Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot study. [electronic resource] by
- Ikeda, K
- Saitoh, S
- Kobayashi, M
- Suzuki, Y
- Suzuki, F
- Tsubota, A
- Arase, Y
- Murashima, N
- Chayama, K
- Kumada, H
Producer: 20010920
In:
Journal of gastroenterology and hepatology vol. 16
Availability: No items available.
|
|
52498.
|
|
|
52499.
|
|
|
52500.
|
|